| Primary |
| Pain |
22.7% |
| Rheumatoid Arthritis |
11.9% |
| Arthritis |
9.7% |
| Back Pain |
9.7% |
| Osteoarthritis |
6.7% |
| Product Used For Unknown Indication |
6.3% |
| Arthralgia |
5.2% |
| Hypertension |
4.5% |
| Thrombosis Prophylaxis |
4.5% |
| Cancer Pain |
2.2% |
| Musculoskeletal Pain |
2.2% |
| Prostate Cancer |
2.2% |
| Drug Use For Unknown Indication |
1.9% |
| Spinal Osteoarthritis |
1.9% |
| Cachexia |
1.5% |
| Insomnia |
1.5% |
| Myocardial Infarction |
1.5% |
| Neck Pain |
1.5% |
| Pain In Extremity |
1.5% |
| Inflammation |
1.1% |
|
| Gastrointestinal Haemorrhage |
12.4% |
| Renal Failure Acute |
12.4% |
| Rectal Haemorrhage |
9.7% |
| Vomiting |
8.0% |
| Gastric Haemorrhage |
7.1% |
| Completed Suicide |
5.3% |
| Urticaria |
5.3% |
| Colitis Microscopic |
4.4% |
| Death |
3.5% |
| Duodenal Ulcer Perforation |
3.5% |
| Pruritus |
3.5% |
| Toxic Epidermal Necrolysis |
3.5% |
| Diarrhoea |
2.7% |
| Haematemesis |
2.7% |
| Hyperkalaemia |
2.7% |
| Oedema Peripheral |
2.7% |
| Pain |
2.7% |
| Pneumothorax |
2.7% |
| Renal Failure |
2.7% |
| Respiratory Arrest |
2.7% |
|
| Secondary |
| Headache |
15.0% |
| Rheumatoid Arthritis |
13.4% |
| Product Used For Unknown Indication |
12.4% |
| Drug Use For Unknown Indication |
9.0% |
| Bone Disorder |
7.5% |
| Respiratory Disorder |
7.5% |
| Pain |
6.6% |
| Prophylaxis |
5.5% |
| Multiple Myeloma |
3.8% |
| Hypertension |
3.3% |
| Back Pain |
2.7% |
| Metastatic Renal Cell Carcinoma |
2.7% |
| Thrombosis Prophylaxis |
2.6% |
| Arthritis |
1.2% |
| Cachexia |
1.2% |
| Cancer Pain |
1.2% |
| Constipation |
1.2% |
| Insomnia |
1.2% |
| Neck Pain |
1.1% |
| Osteoporosis |
1.1% |
|
| Toxicity To Various Agents |
11.2% |
| Completed Suicide |
10.3% |
| Death |
7.5% |
| Drug Hypersensitivity |
7.5% |
| Stomatitis |
5.6% |
| Pain In Extremity |
4.7% |
| Pyrexia |
4.7% |
| Respiratory Arrest |
4.7% |
| White Blood Cell Count Increased |
4.7% |
| Anaemia |
3.7% |
| Atrial Fibrillation |
3.7% |
| Drug Toxicity |
3.7% |
| Interstitial Lung Disease |
3.7% |
| Pleural Effusion |
3.7% |
| Renal Failure |
3.7% |
| Sepsis |
3.7% |
| Somnolence |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Aplastic Anaemia |
2.8% |
| Cardio-respiratory Arrest |
2.8% |
|
| Concomitant |
| Rheumatoid Arthritis |
26.9% |
| Product Used For Unknown Indication |
18.3% |
| Drug Use For Unknown Indication |
12.7% |
| Prophylaxis |
6.8% |
| Pain |
5.8% |
| Hypertension |
4.7% |
| Depression |
3.0% |
| Osteoporosis |
2.7% |
| Insomnia |
2.4% |
| Anxiety |
1.9% |
| Multiple Myeloma |
1.9% |
| Metastatic Renal Cell Carcinoma |
1.7% |
| Arthritis |
1.5% |
| Breast Cancer Metastatic |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Renal Cell Carcinoma |
1.4% |
| Breast Cancer |
1.4% |
| Gastritis |
1.4% |
| Asthma |
1.3% |
| Psoriatic Arthropathy |
1.2% |
|
| Vomiting |
12.8% |
| Pneumonia |
7.2% |
| Rash |
5.9% |
| Pain |
5.8% |
| Weight Decreased |
5.8% |
| Weight Increased |
5.8% |
| Pyrexia |
5.6% |
| Nausea |
5.2% |
| White Blood Cell Count Increased |
5.1% |
| Pulmonary Embolism |
4.7% |
| Type 2 Diabetes Mellitus |
4.7% |
| Urinary Tract Infection |
4.5% |
| Drug Ineffective |
3.8% |
| Myocardial Infarction |
3.5% |
| Rheumatoid Arthritis |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Pneumocystis Jiroveci Pneumonia |
3.3% |
| Headache |
3.1% |
| Hepatic Function Abnormal |
3.1% |
| Wound Treatment |
3.0% |
|
